Fulcrum Therapeutics (FULC) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $13.4 million.
- Fulcrum Therapeutics' Other Gross PP&E Adjustments rose 1531.79% to $13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 million, marking a year-over-year increase of 1531.79%. This contributed to the annual value of $11.8 million for FY2024, which is 1396.68% up from last year.
- Latest data reveals that Fulcrum Therapeutics reported Other Gross PP&E Adjustments of $13.4 million as of Q3 2025, which was up 1531.79% from $12.9 million recorded in Q2 2025.
- Fulcrum Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $14.6 million for Q4 2021, and its period low was $5.3 million during Q1 2022.
- For the 5-year period, Fulcrum Therapeutics' Other Gross PP&E Adjustments averaged around $10.9 million, with its median value being $10.8 million (2024).
- As far as peak fluctuations go, Fulcrum Therapeutics' Other Gross PP&E Adjustments tumbled by 6287.52% in 2022, and later surged by 6150.35% in 2023.
- Fulcrum Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $14.6 million in 2021, then crashed by 45.56% to $8.0 million in 2022, then grew by 29.81% to $10.3 million in 2023, then increased by 13.97% to $11.8 million in 2024, then grew by 13.84% to $13.4 million in 2025.
- Its Other Gross PP&E Adjustments was $13.4 million in Q3 2025, compared to $12.9 million in Q2 2025 and $12.4 million in Q1 2025.